Introducing the FT Tech Tonic podcast. You can subscribe and listen to the rest of the series here. From picking the best stocks to listening in on earnings calls, AI-powered systems are changing finance. But how big are the rewards, really? And what are the risks? In this episode Robin Wigglesworth tells us how AI has been used in investing, what happens when programs must adapt to new risks and what the robots could learn from watching children play.  Alice Fordham is senior producer. Josh Gabert Doyon is assistant producer. Oluwakemi Aladesuyi and Liam Nolan are the development producers. Sound design and mixing by Breen Turner. Cheryl Brumley is the executive producer for this series. Original scoring composed by Metaphor Music.  Review clips: Alphabet, Netflix, Amazon, Man Group. Hosted on Acast. See acast.com/privacy for more information.

The Boston-based biotech eschewed a traditional approach to vaccine development, instead pitching its use of mRNA technology to investors. That pitch paid off this year as the company stands to be one of the first to bring a Covid-19 vaccine to market. Hannah Kuchler, the FT’s US pharma and biotech correspondent, reports on Moderna’s race to find an immunisation for the novel coronavirus.   The FT is making key coronavirus coverage free to read for everyone. Go to ft.com/coronavirusfree to read the latest. Read more here: Moderna’s Covid vaccine offers vindication of its unconventional approach Review clips: Yahoo Finance, CNBC Hosted on Acast. See acast.com/privacy for more information.